2WaldNJ,Hackshaw AK. Cigarettesmoking:an epi demiological overview. Br Med Bull 1996;52:3-11.
3Peto R,Lopez AD, Boreham J,et aI. Mortality from smoking worldwide. Br Med Bull, 1996 ;52 : 12-21.
4World Health Organization. The tobacco epidemic:a global public health emergency. Tobacco Alert. April 1998.http:www. who.int/archives/tobalert/apr96/fulltext.htm.
5Hecht SS. Biochemistry, biology, and carcinogenicity of tobacco-speeitlc N-Nitrosamines. Chem Res Toxico,1998:11:559-603.
6Hoffmann D., Bmnnemann, KD. Prokopczyk, B., and Djiordjievic, MV. Tobacco-specifc N-nitrosamines and areca-derived N-nitrosamines: chemistry, biochemistry,carcinogenicity, and relevance to humans. J, Toxicol.Hralth. 1994:41:1-52.
7Zhou H, Calaf GM, tel TI. Malignant transformation of human bronchial epithelial cells with the tobacco-specific nitrosamine, 4-(methylnitrosamino)- Ⅰ-(3 -pyridyl)- 1-bu-tanone. Int J Cancer.2003;106(6):821-926.
8Cannel la SG, Bomkhova A, Akerkar SA, Hecht SS. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone, a tobacco-specific lung carcinogen. Cancer Epidem Biomar Prey,1997;6:113-120.
9Hecht SS, Carmella SG, Ye M, Le KA, et al. Quantiration of metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-l-butanone after cessation of smokeless tobacco use. Cancer Res,2002;62(1):129-134.
10Finckh C, AtaUa A, Nagd G, Stinner B, Maser E. Expression and NNK reducing activities of carbonyl reductase and llbeta-hydroxy steroid dehydrogenase type I in human lung. Chem Biol Interact,2001;130-132(1-3):76-773.
